GlobalTuberculosis Diagnostic Market is expected to reach $XX Mn by 2026 from $XXMn in 2019, at a CAGR of 5.2% during the forecast period.
Global Tuberculosis DiagnosticMarket Overview:
Tuberculosis or TB is an infectiousdisease caused by Mycobacterium tuberculosis bacteria. Tuberculosis generallyaffects the lungs, but can also affect other parts of the body. Most infectionsdo not have symptoms and this is known as latent tuberculosis. About 10% oflatent infections progress to active disease which, if left untreated, killsabout half of those infected.
Global Tuberculosis DiagnosticMarket Dynamics:
Rising Burden of Tuberculosis andMulti-drug Resistant Tuberculosis (MDR TB) are the primary factors driving themarket growth.
According to the World HealthOrganization (WHO), about 10 million people are affected by tuberculosis, eachyear. Further, tuberculosis is the leading cause of death from a singleinfectious agent, ranking above HIV/AIDS. The rise in initiatives bygovernments and independent organizations to control the spread of tuberculosisis also contributing to the growth of the global tuberculosis diagnosticsmarket. An increase in expenditure on R&D activities for the development ofnovel tuberculosis diagnostic procedures will be a major factor for the growthof the tuberculosis diagnostics market growth in the forecast period. However,the high cost associated with the Tuberculosis testing procedure may hamper themarket growth.
The report has profiled fifteen keyplayers in the market from different regions. However, report has consideredall market leaders, followers and new entrants with investors while analyzingthe market and estimation the size of the same. Increasing R&D activitiesin each region are different and focus is given on the regional impact on thecost, availability of advanced technology are analyzed and report has come upwith recommendations for future hot spot in APAC region.
Global Tuberculosis DiagnosticMarket Segment Analysis:
The Global Tuberculosis DiagnosticMarket is segmented on the basis of Test Type and End-users.
Based on Test Type, the NucleicAcid Testing segment is projected to hold a significant market share. Nucleicacid testing of tuberculosis provides a higher level of accuracy and higherspeed than culture-based tests, which is a factor driving the growth of thenucleic acid testing segment. The segment is expected to witness a CAGR of 5.4%over the forecast years.
Global Tuberculosis DiagnosticMarket1
To Know About The ResearchMethodology :- Request Free Sample Report
Global Tuberculosis DiagnosticMarket Regional Insights:
Global Tuberculosis DiagnosticMarket2
Asia Pacific is expected to witnesslucrative market growth during forecast period.
Due to the high burden oftuberculosis as well as the rapid proliferation of this disease the region isexpected to dominate the market. Countries, such as India, China, Indonesia,and Afghanistan are among the top-priority countries for the control of communicablediseases, according to the WHO. China and India registered the highest numberof new cases of tuberculosis annually, followed by African and Latin Americancountries.
The report also helps inunderstanding Global Tuberculosis Diagnostic Market dynamics, structure byanalyzing the market segments and project the Global Tuberculosis DiagnosticMarket size. Clear representation of competitive analysis of key players byproduct, price, financial position, product portfolio, growth strategies, andregional presence in the Global Tuberculosis Diagnostic Market make the reportinvestor’s guide.
Key Developments:
In June 2018, Qiagen set up newguidelines from the American Academy of Pediatrics (AAP) for screening childrenas young as two years old, for latent tuberculosis infection.
Global Tuberculosis DiagnosticMarket Scope: Inquire before buying
Global Tuberculosis DiagnosticMarket3
Global Tuberculosis DiagnosticMarket, By Region:
• North America
• Europe
• South America
• MEA
• APAC
Global Tuberculosis DiagnosticMarket, key players:
• Thermo Fisher Scientific, Inc.
• Alere, Inc.
• Becton
• Dickinson and Company
• F. Hoffmann-La Roche AG
• LIONEX Diagnostics &Therapeutics GmbH
• Danaher Corporation
• Creative Diagnostics
• QIAGEN
• Oxford Immunotec Ltd.
• Hologic, Inc.
• Cepheid
• Akonni Biosystems, Inc.
• bioMerieux SA
• Epistem Ltd.
For More Information Vist : https://www.maximizemarketresearch.com/market-report/global-tuberculosis-diagnostic-market/94559/
Report Is Submitted By : MaximizeMarket Research Company
Customization of the report:
Maximize Market Research of reportsas per your demand. This report can be personalized to meet your requirements.Get in touch with us and our sales team will guarantee provide you to get areport that suits your necessities.
About Maximize Market Research:
Maximize Market Research providesB2B and B2C research on 20,000 high growth emerging opportunities &technologies as well as threats to the companies across the Healthcare,Pharmaceuticals, Electronics & Communications, Internet of Things, Food andBeverages, Aerospace and Defense and other manufacturing sectors.
